Bubacco, Luigi

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE

Inflammasome and immune disordersParkinson's Disease Mechanisms and Treatments

Cited by 585

Kinetic and Structural Analysis of the Early Oxidation Products of Dopamine

Bisaglia, M., Mammi, S., & Bubacco, L. (2007) · Journal of Biological Chemistry

Parkinson's Disease Mechanisms and TreatmentsRedox biology and oxidative stress

Cited by 303

Ceftriaxone Blocks the Polymerization of α-Synuclein and Exerts Neuroprotective Effects in Vitro

Ruzza, P., Siligardi, G., Hussain, R., Marchiani, A., Islami, M., Bubacco, L., Delogu, G., Fabbri, D., Dettori, M. A., Sechi, M., et al. (2014) · ACS Chemical Neuroscience

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 70

PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner

Iannotta, L., Fasiczka, R., Favetta, G., Zhao, Y., Giusto, E., Dall'Ara, E., Wei, J., Ho, F., Ciriani, C., Cogo, S., et al. (2024) · Cell Death and Disease

Parkinson's Disease Mechanisms and TreatmentsGenetic and Kidney Cyst Diseases

Cited by 5